1.45
Precedente Chiudi:
$1.50
Aprire:
$1.47
Volume 24 ore:
109.03K
Relative Volume:
0.03
Capitalizzazione di mercato:
$25.43M
Reddito:
$174.80K
Utile/perdita netta:
$-8.85M
Rapporto P/E:
-2.1054
EPS:
-0.6887
Flusso di cassa netto:
$-4.37M
1 W Prestazione:
-2.03%
1M Prestazione:
+59.32%
6M Prestazione:
-18.99%
1 anno Prestazione:
-54.11%
Nexalin Technology Inc Stock (NXL) Company Profile
Nome
Nexalin Technology Inc
Settore
Industria
Telefono
(832) 260-0222
Indirizzo
1776 YORKTOWN, HOUSTON
Confronta NXL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
NXL
Nexalin Technology Inc
|
1.46 | 27.28M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
122.90 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.56 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.58 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.31 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
81.21 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Nexalin Technology Inc Borsa (NXL) Ultime notizie
Will Nexalin Technology Inc. Equity Warrant stock benefit from automationMarket Risk Analysis & Low Risk Investment Opportunities - newser.com
How Nexalin Technology Inc. stock compares to industry benchmarksAnalyst Downgrade & High Conviction Buy Zone Alerts - newser.com
Can Nexalin Technology Inc. stock double in next 5 yearsMarket Movement Recap & AI Forecasted Entry and Exit Points - newser.com
Price action breakdown for Nexalin Technology Inc. Equity Warrant2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Should you wait for a breakout in Nexalin Technology Inc.July 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
What high frequency data says about Nexalin Technology Inc. Equity WarrantMarket Sentiment Report & Community Verified Trade Alerts - newser.com
Is this a good reentry point in Nexalin Technology Inc.Short Setup & Daily Technical Forecast Reports - newser.com
Detecting support and resistance levels for Nexalin Technology Inc.Fed Meeting & Weekly High Potential Stock Alerts - newser.com
What data driven models say about Nexalin Technology Inc.’s futureEarnings Trend Report & Growth Focused Stock Reports - newser.com
What momentum shifts mean for Nexalin Technology Inc.2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com
Will Nexalin Technology Inc. Equity Warrant stock benefit from AI adoptionDay Trade & AI Enhanced Trading Signals - newser.com
Price momentum metrics for Nexalin Technology Inc. explainedPortfolio Return Summary & Safe Entry Momentum Tips - newser.com
Momentum divergence signals in Nexalin Technology Inc. chartWeekly Stock Summary & Safe Swing Trade Setup Alerts - newser.com
Is Nexalin Technology Inc. forming a bottoming basePortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
Why Nexalin Technology Inc. stock is in analyst buy zoneJuly 2025 Chart Watch & Free Reliable Trade Execution Plans - newser.com
Can Nexalin Technology Inc. stock outperform in 2025 bull marketJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - newser.com
Analyzing Nexalin Technology Inc. with multi timeframe charts2025 Technical Overview & Community Consensus Picks - newser.com
Can Nexalin Technology Inc. stock reach $100 price target2025 Earnings Surprises & AI Driven Price Predictions - newser.com
How to monitor Nexalin Technology Inc. Equity Warrant with trend dashboards2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Will Nexalin Technology Inc. stock sustain high P E ratiosJuly 2025 Short Interest & Weekly Breakout Watchlists - newser.com
Statistical indicators supporting Nexalin Technology Inc.’s strength2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Is Nexalin Technology Inc. stock a buy for dividend growthStock Surge & Scalable Portfolio Growth Ideas - newser.com
Is a relief rally coming for Nexalin Technology Inc. Equity Warrant holders2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Is Nexalin Technology Inc. Equity Warrant stock bottoming out2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Historical volatility pattern of Nexalin Technology Inc. Equity Warrant visualized2025 Big Picture & Short-Term High Return Strategies - newser.com
How geopolitical tensions affect Nexalin Technology Inc. stockEarnings Growth Report & Safe Capital Growth Plans - newser.com
Regression analysis insights on Nexalin Technology Inc. performanceTrend Reversal & Verified Technical Signals - newser.com
What institutional flow reveals about Nexalin Technology Inc. Equity WarrantIndex Update & Fast Exit/Entry Strategy Plans - newser.com
Published on: 2025-11-01 03:03:09 - newser.com
Can momentum traders help lift Nexalin Technology Inc.Market Rally & Advanced Technical Signal Analysis - newser.com
Can Nexalin Technology Inc. stock attract ESG capital inflowsWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
Nexalin Technology Inc Azioni (NXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Nexalin Technology Inc Azioni (NXL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):